Genetic testing for critically ill newborns
Part of Digestive system clinical trials.
This study uses a two-step genetic test (fast whole-genome sequencing followed by RNA testing if needed) to find the cause of unexplained, life-threatening conditions in newborns. The goal is to get a precise diagnosis faster, which could guide better care for your baby.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be under 3 months old and critically ill in the hospital.
- Doctors suspect a genetic disease because of unusual symptoms or family history.
- You or the legal guardian must agree to fast genetic testing and possible additional RNA testing.
- Your baby cannot already have a known genetic diagnosis that explains their illness.
- You must be willing to fully cooperate with the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study offers genetic testing for infants under 18 months who are in intensive care with certain health problems that may be genetic. The goal is to find a genetic cause quickly, which could guide care and treatment.
This study uses whole-genome sequencing (a DNA test that looks across the genome) for newborns in the intensive care unit when doctors suspect a genetic condition. It aims to help identify possible genetic causes of illness and improve understanding for families and clinicians.
This study looks at using rapid DNA testing (genomics) in newborns and children who are very sick in the hospital (NICU or PICU). The goal is to see if finding a genetic cause early can help guide treatment and improve outcomes.
This research study tests a new way to screen newborns for hundreds of genetic diseases using a sample of their blood or saliva. It aims to find conditions early so your baby can get the right care sooner.
This study looks at using whole genome sequencing in newborns and families with ongoing pregnancies, including those conceived naturally or with fertility treatments. It aims to better understand and manage genetic disease risks early.
This study quickly reads a child’s DNA using whole genome sequencing to look for genetic causes of symptoms. It may help families and doctors better understand an underlying genetic condition and guide medical care.
Hear when a new Necrotizing Enterocolitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.